EU Chemicals Output Impacted by Pandemic

Despite “encouraging” signs of a recovery of chemical production in May from the coronavirus-related “historic slump” in March and April, progress is now slowing, the European Chemical Industry Council (CEFIC) said in its report on the first nine months of 2020.

Looking at the figures for the first three quarters, CEFIC says the EU 27’s chemical output sank 4.4% against the same period of 2019, due in part to the 10.6% downswing in EU manufacturing as a whole.

Significantly, EU exports outside the bloc up to August, at €111.7 billion, were 5.5% below the 2019 level. At €86.4 billion, chemical imports from outside the 27-member bloc in the first eight months were almost 4% below the same period.

Among the large chemical-producing countries represented by the industry association, companies in France and Italy – where production sank 10% and 13% respectively – were the most negatively impacted by the virus-triggered crisis in the first three quarters, followed by Spain, Belgium and Portugal with 4%. Germany’s output sank 3.6%, that of the UK by 1.7%. Poland’s production was flat.

Globally, chemicals output declined 1.8% from January to September. China stood out positively, with a rise of 0.7%. The People’s Republic is showing a V-shaped recovery from the Covid-19 crisis, CEFIC’s data shows, and its output level was the highest ever in September.

In the rest of the world, the poor consumer economy took its toll, with Japan (down 10.7%) and India (down 9.4%) most severely affected. Figures for the US, with a 4.5% drop, were in line with the EU 27.

Looking at the industries chemical producers supply, the association’s figures point clearly to the automotive sector, with a deterioration of 28% against the 2019 period, as the worst hit, followed by basic metals with a setback of 15.5%. The plastics and rubber sector’s output sank 11%. Electrical appliances saw a decrease of around 4.5%. Production of chemicals for the food and beverage sector held up best, with a decline of only 2.6%.

In the first eight months, EU chemical producers saw sales revenue recede by 9% to €318.2 billion, due to weak order volume within the 27-member bloc and the deterioration of the trade business environment altogether. Capacity utilization at the end of September was still 7.7% below the previous year’s level. Selling prices deteriorated by 5%.

CEFIC does not attempt to estimate how figures will develop in the coming months. However, director-general Marco Mensink says the current wave of Covid infections is “serious,” and will continue to impact chemical businesses.  This outlook, he says, “underpins the need for rapid approval and implementation of the EU Economic Recovery Plan, which needs to be firmly embedded in the EU Industrial Strategy and the Green Deal agenda.”

Author: Dede Williams, Freelance Journalist

Despite “encouraging” signs of a recovery of chemical production in May...
Despite “encouraging” signs of a recovery of chemical production in May from the coronavirus-related “historic slump” in March and April, progress is now slowing, CEFIC said in its report on the first nine months of 2020. The EU 27’s chemical output sank 4.4% year on year. (c) Johannes Plenio

Interview

Fostering Innovation and Collaboration
Specialty Chemicals Distributor IMCD’s Strategy

Fostering Innovation and Collaboration

Valerie Diele-Braun, CEO of IMCD, shares her vision for sustainability, global expansions, and strategic direction in an exclusive CHEManager International interview.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
08.11.2024 • News

Future Prospects in Green Chemistry

The Discourse on Green Chemistry Interactive Pitch Competition, held on November 5, 2024, at Wiley's Berlin office as part of Berlin Science Week, showcased a range of innovative projects aimed at addressing critical environmental challenges.

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.

Photo
29.10.2024 • News

GSK to Invest $800 Million in US Manufacturing Facility

British pharma company GlaxoSmithKline (GSK) plans to invest up to $800 million to expand drug substance and drug product manufacturing capabilities at the company’s US site in Marietta, Pennsylvania. The investment, which GSK said is its largest ever in US manufacturing, is expected to create more than 200 new jobs.

Photo
27.03.2025 • News

J&J to Invest $55 Billion in US Operations

US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.